icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
xpGnArrR9P4bVQav
Listen
